|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Development of a biochemotherapy regimen with concurrent,administration of cisplation,vinblastine,dacarbazine,interferon alfa,and interleukin-2 for patients with metastatic melanoma显示文摘 | Legha SS Ring S Eton O | 1998 | J Clin Oncol1998，16，5： | 1 |
| 2 | Phase II trial of imatinib mesylate (STI-571) in metastatic melanoma (MM)显示文摘 | Eton O Billings L Kim K | 2004 | J Clin Oncol2004，22，： | 1 |
| 3 | Analysis of protein tyrosine kinase expression in melanocytic lesions by tissue array 显示文摘 | Shen SS Zhang PS Eton O | 2003 | J Cutan Pathol2003，30，9： | 1 |
| 4 | Chemotherapy, cytokines, and biochemotherapy for melano- ma显示文摘 | Eton O | 2005 | Cancer Chemother Biol Response Modif2005，22，22： | 1 |
| 5 | Sequential bioehemotherapy versus chemotherapy for metastatic melanoma;results from a phase III randomized trial显示文摘 | Eton O Legha SS Bedikian AY | 2002 | J Clin Oncol2002，20，8： | 1 |
| 6 | Phase II trial of imatinib mesylate in patients with metastatic melanoma 显示文摘 | Kim KB Eton O Davis DW | 2008 | Br J Cancer2008，99，5： | 1 |
| 7 | Analysis of protein tyrosine kinase expression in melanocytic lesions by tissue array 显示文摘 | Shen SS Zhang PS Eton O | 2003 | J Cutan Pathol2003，30，9： | 1 |
| 8 | Development of a biochemotherapy regimen with concurrent ainistration of cisplatin,vinblastine,dacarbazine,interferon alfa,and interleukin-2 for patients with metastatic melanoma显示文摘 | LEGHA S S RING S ETON O | 1998 | J Clin Oncol1998，16，5： | 1 |
| 9 | Chemotherapy, cytokines, and biochemotherapy for melanoma 显示文摘 | Eton O | 2005 | Cancer Chemother Biol Response Modif2005，22，： | 1 |
| 10 | Phase II trial of imatinib mesylate in patients with metastatic melanoma显示文摘 | Kim K B Eton O Davis D W | 2008 | Br J Cancer2008，99，5： | 1 |
| 11 | Autologous tumor-derived heatshock protein peptide complex-96 (HSPPC-96) in patients (PTS) with metastatic melanoma显示文摘 | Eton O East MJ Ross M | 2000 | Proc of the Am Assoc for Canc Res2000，41，： | 1 |
| 12 | Autologous tumor-derived heat-shock protein peptide complex-96(HSPPC-96)in patients with metastatic melanoma显示文摘 | Eton O Ross MI East MJ | | 0，，： | 1 |
| 13 | Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase Ⅲ randomized trial 显示文摘 | Eton O Legha SS Bedikian AY | 2002 | J Clin Oncol2002，20，： | 1 |
| 14 | Phase Ⅱ trial of imatinib mesylate in patients with metastatic melanoma 显示文摘 | Kim KB Eton O Davis DW | 2008 | Br J Cancer2008，99，5： | 1 |
| 15 | Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase Ⅲ randomized trial 显示文摘 | Eton O Legha S S Bedikian A Y | 2002 | J Clin Oncol2002，20，8： | 1 |
| 16 | Development of a biochemotherapy regimen with concurrent,a dministration of cisplation,vinblastine,dacarbazine,interferon alfa,and interleukin-2 for patients with metastatic melanoma显示文摘 | Legha SS Ring S Eton O | 1998 | J Clin Oncol1998，16，5： | 1 |
| 17 | Chemotherapy, cytokines, and biochemotherapy for melanoma cancer 显示文摘 | Eton O | 2005 | Chernother Biol Response Modif2005，22，： | 1 |
| 18 | Autologous tumor-derived heat shock protein peptide complex296 (HSPPC296) in patients (PTS) with metastatic melanoma 显示文摘 | Eton O East MJ Ross M | 2000 | Proc of the A m Assoc f or Canc Res2000，41，： | 1 |
| 19 | Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinhlasbine, dacarhazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma显示文摘 | Legha SS Ring S Eton O | 1998 | J Clin Onco11998，16，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员